Cargando…
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy
A 72-year-old immunocompromised man infected with severe acute respiratory syndrome coronavirus 2 received bamlanivimab monotherapy. Viral evolution was monitored in nasopharyngeal and blood samples by melting curve analysis of single-nucleotide polymorphisms and whole-genome sequencing. Rapid emerg...
Autores principales: | Truffot, Aurélie, Andréani, Julien, Le Maréchal, Marion, Caporossi, Alban, Epaulard, Olivier, Germi, Raphaele, Poignard, Pascal, Larrat, Sylvie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462331/ https://www.ncbi.nlm.nih.gov/pubmed/34352197 http://dx.doi.org/10.3201/eid2710.211509 |
Ejemplares similares
-
Virological Markers in Epstein–Barr Virus-Associated Diseases
por: Lupo, Julien, et al.
Publicado: (2023) -
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
por: Epaulard, Olivier, et al.
Publicado: (2022) -
Towards real-time monitoring of COVID-19 nosocomial clusters using SARS-CoV-2 genomes in a university hospital of the French Alps
por: Gallouche, Meghann, et al.
Publicado: (2023) -
Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results
por: Lupo, Julien, et al.
Publicado: (2022) -
Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?
por: Andreani, Julien, et al.
Publicado: (2021)